Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization

Abstract

We demonstrate that on a genomic scale, that although STS is radioresistant overall, they are heterogeneous in terms of radiosensitivity. We validated this clinically and estimated an α/β ratio and dosing that would optimize outcome, personalizing dose.